コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 t complications of allogeneic bone marrow or peripheral blood stem cell transplantation.
2 chemotherapy, whole-brain radiotherapy, and peripheral blood stem cell transplantation.
3 severity of graft-versus-host disease after peripheral blood stem cell transplantation.
4 ive patients undergoing autologous marrow or peripheral blood stem cell transplantation.
5 on, he underwent high-dose chemotherapy with peripheral blood stem cell transplantation.
6 hrough 1997 who would have been eligible for peripheral-blood stem-cell transplantation.
7 noma by means of nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.
9 hy caused by JC papovavirus after autologous peripheral blood stem cell transplantation and a case ea
10 corticosteroid-requiring chronic GVHD after peripheral blood stem cell transplantation and should be
11 ving chemotherapy with or without autologous peripheral blood stem cell transplantation (APBSCT).
12 lymphoma who underwent autologous marrow or peripheral-blood stem-cell transplantation at our instit
13 myeloma, particularly high-dose therapy with peripheral blood stem cell transplantation, can achieve
14 herapy followed by autologous bone marrow or peripheral-blood stem-cell transplantation for patients
15 ion in chronic GVHD 2 years after allogeneic peripheral-blood stem-cell transplantation from an HLA-i
16 with chronic granulomatous disease underwent peripheral-blood stem-cell transplantation from an HLA-i
17 elphalan chemotherapy followed by autologous peripheral blood stem cell transplantation (HDM/SCT) can
18 h-dose melphalan chemotherapy and autologous peripheral blood stem cell transplantation (HDM/SCT) hav
19 ed (1-2 x 10(4) T cells/kg) nonmyeloablative peripheral blood stem cell transplantation in children a
20 arrow and lymph node irradiation (TMLI), for peripheral blood stem cell transplantation, in patients
24 h-dose carboplatin and etoposide followed by peripheral-blood stem-cell transplantation or autologous
25 t our institution with high-dose therapy and peripheral blood stem cell transplantation (PBSCT) follo
27 on the improved response rates observed with peripheral blood stem cell transplantation (PBSCT) in pa
30 evious multicenter phase III trial comparing peripheral blood stem cell transplantation (PBSCT) to bo
31 st survival is better in patients undergoing peripheral blood stem cell transplantation (PBSCT), but
33 transplantation (ABMT) (n = 46) or mobilized peripheral-blood stem-cell transplantation (PBSCT) (n =
34 eated with high-dose chemotherapy (HDCT) and peripheral-blood stem-cell transplantation (PBSCT) at In
35 ersus-host disease (GVHD) is increased after peripheral-blood stem-cell transplantation (PBSCT) when
37 by autologous bone marrow transplantation or peripheral blood stem-cell transplantation (referred to
38 c graft-versus-host disease after allogeneic peripheral blood stem-cell transplantation who had sever
39 n (180 mg/m(2) intravenously) and autologous peripheral blood stem cell transplantation, with marked
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。